Xifró, Xavier <br/><br/>
Novel epigallocatechin-3-gallate (EGCG) derivative as a new therapeutic strategy for reducing neuropathic pain after chronic constriction nerve injury in mice.  [electronic resource] 

 -  PloS one  2015 
 - e0123122 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0123122  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Catechin--administration & dosage<br/>Cell Membrane--drug effects<br/>Cytokines--biosynthesis<br/>Fatty Acid Synthase, Type I--biosynthesis<br/>Fatty Acids--metabolism<br/>Gene Expression Regulation--drug effects<br/>Hyperalgesia--drug therapy<br/>Male<br/>Mice<br/>Neuralgia--drug therapy<br/>Pain--drug therapy<br/>Pain Threshold<br/>Peripheral Nerve Injuries<br/>Spinal Cord Injuries--drug therapy